Epidemiology Study and Risk Factor Analysis on Chronic Post-surgical Pain After Video-assisted Thoracic Surgery
A Nationwide Multi-center Epidemiology Study and Risk Factor Analysis on Chronic Post-surgical Pain After Video-assisted Thoracic Surgery
1 other identifier
observational
886
1 country
1
Brief Summary
This study is a nationwide multi-center study to investigate the incidence and risk factors of chronic post-surgical pain (CPSP) after receiving video-assisted thoracic surgery (VATS). Patients receiving VATS in participating centers across China in Aug. 2022 will be assessed for eligibility, and all the enrolled patients will be followed up for at least 6 months. The study's primary outcome is the incidence of CPSP 6 months after VATS. Baseline demographic, psychological , surgical, anesthesia-related and pain-related characteristics will be evaluated for possible risk factors of CPSP after VATS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 24, 2022
CompletedFirst Posted
Study publicly available on registry
July 26, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedMay 13, 2024
May 1, 2024
9 months
July 24, 2022
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
post-surgical pain-6 month
Asking patients about the existence of chronic pain related to surgery by telephone interview
6 month after the VATS
Secondary Outcomes (2)
post-surgical pain-3 month
3 month after the VATS
Influence on quality of life
3\6 month after the VATS
Eligibility Criteria
Our research focuses on the incidence of CPSP after VATS in Chinese population. So, our target population will be all the Chinese patients receiving VATS in China. To select an accessible population that can well represent the target population, we set geographic criteria as regional medical centers in all seven geographical subregions of China, namely northwestern China, northern China, northeastern China, central China, southern China, southwestern China and southeastern China. Considering the needed sample size and the cost, we set time criteria as one month. Therefore, the accessible population in our study is all the patients receiving VATS in Aug., 2022 at selected medical centers in all seven geographical subregions of China.
You may qualify if:
- In-patients at participating medical centers
- Scheduled for unilateral VATS during the study enrollment period
You may not qualify if:
- Emergency surgeries
- Patients with known pain sensory impairment
- Patients cannot express themselves so that an NRS score cannot be measured
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Union Medical College Hospitallead
- Cancer Institute and Hospital, Chinese Academy of Medical Sciencescollaborator
- Tianjin Medical University Cancer Institute and Hospitalcollaborator
- First Affiliated Hospital of Chongqing Medical Universitycollaborator
- Xiangya Hospital of Central South Universitycollaborator
- Shanghai Chest Hospitalcollaborator
- The Affiliated Hospital of Inner Mongolia Medical Universitycollaborator
- The people's hospital of Xinjiangcollaborator
- Cancer hospital affiliated to Xinjiang Medical Universtitycollaborator
- Gansu provincial hospital of TCMcollaborator
- Tibet Autonomous Region People's Hospitalcollaborator
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Le Shen, M.D., Ph.D.
Peking Union Medical College Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2022
First Posted
July 26, 2022
Study Start
August 1, 2022
Primary Completion
May 1, 2023
Study Completion
June 30, 2023
Last Updated
May 13, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
In terms to patient's privacy, only the overall statistics will be reported. (i.e. incidence, risk factors, demographic characteristics). Individual date will not be available to other researchers.